New strategy for suppressing the growth of lung cancer cells harboring mutations in the ATP-binding region of EGFR by targeting the molecular motor MYO1D.
Ko YS, Kang H, Bae JA, Kim SJ, Kim N, Chung IJ, Moon KS, Rho JK, Kim H, Ha HH, et al. Clin Transl Med. 2021 Aug; 11(8):e515.